The curse of commanding the Afghan war

A look at what went wrong for the four U.S. generals who have led U.S. and NATO forces in Afghanistan since 2008:

Gen. David McKiernan, June 2008 to June 2009

-Defense Secretary Robert Gates asked for McKiernan's resignation a year before his term as commander was set to end. The firing was seen as a rejection by newly elected President Barack Obama of McKiernan's conventional warfare approach in favor of the more targeted "counterinsurgency" strategy of working to undermine insurgents' pull on the population.

Gen. Stanley A. McChrystal, June 2009 to June 2010

-McChrystal, who had a background in special operations, came in with a mandate to remake the war effort with the help of "surge" troops ordered by Obama. A year into that push, an article in Rolling Stone magazine quoted members of McChrystal's team making disparaging comments about their commander in chief and other senior administration officials. Obama called McChrystal back to Washington to explain and forced him to resign.

Gen. David Petraeus, July 2010 to July 2011

-Petraeus took over the Afghan command to fill the void left by McChrystal's abrupt departure and agreed to serve for one year. He completed that term and then retired from the military to become CIA director in September 2011. Petraeus resigned as CIA director on Nov. 9 after he had an extramarital affair with his biographer. The affair came out as part of an FBI investigation into suspicious emails between the biographer and another woman.

Gen. John Allen, July 2011 to present

-Allen was appointed by Obama to oversee the drawdown of U.S. and international forces ahead of the planned transfer of security responsibility to the Afghan government in 2014. Pentagon officials said early Tuesday that Allen is under investigation for thousands of alleged "inappropriate communications" with the second woman involved in the Petraeus case, a Florida socialite. Allen's nomination to become the next commander of U.S. European Command and the commander of NATO forces in Europe has now been put on hold.

Read More..

RIM sees BB10 devices in stores soon after launch

WATERLOO, Ontario (Reuters) – Research In Motion is confident its new BlackBerry 10 devices will be 100 percent ready for the January 30 launch and available in stores “not too long after” that, Chief Operating Officer Kristian Tear said on Tuesday.

“We’re working hard right now to make sure all the bits and pieces and all the details are in place for the date, when the devices will be available for consumers and enterprises,” Tear told Reuters in an interview.

RIM, which virtually invented the concept of mobile email with its first line of BlackBerry devices more than a decade ago, was roundly criticized for the botched 2011 launch of its PlayBook tablet computer, which RIM had hoped would compete with Apple’s blockbuster iPad.

The PlayBook looked pretty and had top-of-the-line hardware. But its software was far from complete at the launch and needed multiple updates.

The device also lacked the library of apps available on the iPad and on devices that run on Google Inc’s competing Android operating system.

RIM says its the new devices will be faster and smoother than its existing phones and have a large catalog of applications that are crucial to the success of any smartphone.

The company hopes the new devices will allow it to claw back some of the market share it has lost to Android and Apple phones.

Tear said RIM has used input from current BlackBerry users to influence the design of the new devices, The new phones both build on the strengths of RIM’s existing operating system and improve on its weak points, he said.

RIM last month began carrier testing on the new devices, with an initial rollout to more than 50 carriers. Tear, who joined RIM a few months ago from Sony Mobile Communications, said RIM was expanding that to a wider group of carriers across the globe.

“We submitted to 50 carriers to begin with, and obviously that number is increasing as we move forward,” he said. “Our ambition is to make this a global launch, everything will not happen at the same time, but it will be a global launch.”

RIM has said it initially plans to roll out a high-end touchscreen version of the device. Phones with the mini QWERTY keyboards that many long-time BlackBerry users adore will come a few weeks later, while lower-end versions of both devices will be launched later in the year.

The company has yet to say exactly when the devices will be available in stores worldwide or how much they will cost.

“We have to agree with carriers as well on what they want to announce when, so it’s not absolutely to our own discretion,” Tear said.

COST CUTTING

RIM, whose share price has fallen more than 90 percent from a 2008 peak around $ 148, is part way through a major restructuring, as it seeks to trim costs in the run-up to the launch of the new devices.

The company, which has also said it is examining its strategic options, is lowering operating costs by about $ 1 billion and cutting about 5,000 jobs, or about 30 percent of its workforce, by the time its fiscal year ends in early March.

“We are on track to deliver on that,” said Tear. “It is an ongoing process, when it comes to efficiencies and costs.”

RIM’s Chief Legal Officer Steve Zipperstein said the company is pushing ahead with its strategic review.

“The process is ongoing and it continues to be a focus on RIM’s senior management, but we have nothing to report at this moment,” said Zipperstein.

RIM shares, which have risen slightly over the last couple of months in the run-up to the launch of BB10 devices, closed 4.7 percent lower at $ 8.40 on Nasdaq. RIM’s Toronto-listed shares fell by a similar margin to C$ 8.40.

(Reporting by Euan Rocha; Editing by Janet Guttsman, Leslie Adler and Tim Dobbyn)

Gadgets News Headlines – Yahoo! News

Read More..

Man who accused Elmo puppeteer of teen sex recants

NEW YORK (AP) — A man who accused Elmo puppeteer Kevin Clash of having sex with him when he was a teenage boy has recanted his story.

In a quick turnabout, the man on Tuesday described his sexual relationship with Clash as adult and consensual.

Clash responded with a statement of his own, saying he is "relieved that this painful allegation has been put to rest." He had no further comment.

The man, who has not identified himself, released his statement through the Harrisburg, Pa., law firm Andreozzi & Associates.

Sesame Workshop, which produces "Sesame Street" in New York, soon followed by saying, "We are happy that Kevin can move on from this unfortunate episode."

The whirlwind episode began Monday morning, when Sesame Workshop startled the world by announcing that Clash had taken a leave of absence from "Sesame Street" in the wake of allegations that he had had a relationship with a 16-year-old.

Clash, a 52-year-old divorced father of a grown daughter, swiftly denied the charges of his accuser, who is in his early 20s. In that statement Clash acknowledged that he is gay but said the relationship had been between two consenting adults.

Though it remained unclear where the relationship took place, sex with a person under 17 is a felony in New York if the perpetrator is at least 21.

Sesame Workshop, which said it was first contacted by the accuser in June, had launched an investigation that included meeting with the accuser twice and meeting with Clash. Its investigation found the charge of underage conduct to be unsubstantiated.

Clash said on Monday he would take a break from Sesame Workshop "to deal with this false and defamatory allegation."

Neither Clash nor Sesame Workshop indicated on Tuesday when he might return to the show, on which he has performed as Elmo since 1984.

Elmo had previously been a marginal character, but Clash, supplying the fuzzy red puppet with a high-pitched voice and a carefree, child-like personality, launched the character into major stardom. Elmo soon rivaled Big Bird as the face of "Sesame Street."

Though usually behind the scenes, Clash meanwhile achieved his own measure of fame. In 2006, he published an autobiography, "My Life as a Furry Red Monster," and he was the subject of the 2011 documentary "Being Elmo: A Puppeteer's Journey."

He has won 23 daytime Emmy awards and one prime-time Emmy.

___

Online:

http://www.sesamestreet.org

Read More..

Report: FDA wanted to close Mass pharmacy in 2003

WASHINGTON (AP) — Nearly a decade ago, federal health inspectors wanted to shut down the pharmacy linked to a recent deadly meningitis outbreak until it cleaned up its operations, according to congressional investigators.

About 440 people have been sickened by contaminated steroid shots distributed by New England Compounding Center, and more than 32 deaths have been reported since the outbreak began in September, according to the Centers for Disease Control and Prevention. That has put the Framingham, Mass.-based pharmacy at the center of congressional scrutiny and calls for greater regulation of compounding pharmacies, which make individualized medications for patients and have long operated in a legal gray area between state and federal laws.

The House Energy and Commerce Committee released a detailed history of NECC's regulatory troubles on Monday, ahead of a meeting Wednesday meeting to examine how the outbreak could have been prevented. The 25-page report summarizes and quotes from FDA and state inspection memos, though the committee declined to release the original documents.

The report shows that after several problematic incidents, Food and Drug Administration officials in 2003 suggested that the compounding pharmacy be "prohibited from manufacturing" until it improved its operations. But FDA regulators deferred to their counterparts in Massachusetts, who ultimately reached an agreement with the pharmacy to settle concerns about the quality of its prescription injections.

The congressional report also shows that in 2003 the FDA considered the company a pharmacy. That's significant because in recent weeks public health officials have charged that NECC was operating more as a manufacturer than a pharmacy, shipping thousands of doses of drugs to all 50 states instead of small batches of drugs to individual patients. Manufacturers are regulated by the FDA and are subject to stricter quality standards than pharmacies.

The report offers the most detailed account yet of the numerous regulatory complaints against the pharmacy, which nearly date back to its founding in 1998. Less than a year later, the company was cited by the state pharmacy board for providing doctors with blank prescription pads with NECC's information. Such promotional items are illegal in Massachusetts and the pharmacy's owner and director, Barry Cadden, received an informal reprimand, according to documents summarized by the committee.

Cadden was subject to several other complaints involving unprofessional conduct in coming years, but first came to the FDA's attention in 2002. Here are some key events from the report highlighting the company's early troubles with state and federal authorities:

__ In March of 2002 the FDA began investigating reports that five patients had become dizzy and short of breath after receiving NECC's compounded betamethasone repository injection, a steroid used to treat joint pain and arthritis that's different from the one linked to the current meningitis outbreak.

FDA inspectors visited NECC on April 9 and said Cadden was initially cooperative in turning over records about production of the drug. But during a second day of inspections, Cadden told officials "that he was no longer willing to provide us with any additional records," according to an FDA report cited by congressional investigators. The inspectors ultimately issued a report citing NECC for poor sterility and record-keeping practices but said that "this FDA investigation could not proceed to any definitive resolution," because of "problems/barriers that were encountered throughout the inspection."

__ In October of 2002, the FDA received new reports that two patients at a Rochester, N.Y., hospital came down with symptoms of bacterial meningitis after receiving a different NECC injection. The steroid, methylprednisolone acetate, is the same injectable linked to the current outbreak and is typically is used to treat back pain. Both patients were treated with antibiotics and eventually recovered, according to FDA documents cited by the committee.

When officials from the FDA and Massachusetts Board of Pharmacy visited NECC later in the month, Cadden said vials of the steroid returned by the hospital had tested negative for bacterial contamination. But when FDA scientists tested samples of the drug collected in New York they found bacterial contamination in four out of 14 vials sampled. It is not entirely clear whether FDA tested the same lot shipped to the Rochester hospital.

__ At a February 2003 meeting between state and federal officials, FDA staff emphasized "the potential for serious public consequences if NECC's compounding practices, in particular those relating to sterile products, are not improved." The agency issued a list of problems uncovered in its inspection to NECC, including a failure to verify if sterile drugs met safety standards.

But the agency decided to let Massachusetts officials take the lead in regulating the company, since pharmacies are typically regulated at the state level. It was decided that "the state would be in a better position to gain compliance or take regulatory action against NECC as necessary," according to a summary of the meeting quoted by investigators.

The FDA recommended the state subject NECC to a consent agreement, which would require the company to pass certain quality tests to continue operating. But congressional investigators say Massachusetts Board of Pharmacy did not take any action until "well over a year later."

__ In October 2004, the board sent a proposed consent agreement to Cadden, which would have included a formal reprimand and a three-year probationary period for the company's registration. The case ended without disciplinary action in 2006, when NECC agreed to a less severe consent decree with the state.

Massachusetts officials indicated Tuesday they are still investigating why NECC escaped the more severe penalty.

"I will not be satisfied until we know the full story behind this decision," the state's interim health commissioner Lauren Smith said in a transcript of her prepared testimony released a day ahead of delivery. Smith is one of several witnesses scheduled to testify Wednesday, including FDA Commissioner Margaret Hamburg.

The committee will also hear from the widow of 78-year-old Eddie C. Lovelace, a longtime circuit court judge in southern Kentucky. Autopsy results confirmed Lovelace received fungus-contaminated steroid injections that led to his death Sept. 17.

Joyce Lovelace will urge lawmakers to work together on legislation to stop future outbreaks caused by compounded drugs, according to a draft of her testimony.

"We now know that New England Compounding Pharmacy, Inc. killed Eddie. I have lost my soulmate and life's partner with whom I worked side by side, day after day for more than fifty years," Lovelace states.

Barry Cadden is also scheduled to appear at the hearing, after lawmakers issued a subpoena to compel him to attend.

The NECC has been closed since early last month, and Massachusetts officials have taken steps to permanently revoke its license. The pharmacy has recalled all the products it makes, including 17,700 single-dose vials of a steroid that tested positive for the fungus tied to the outbreak.

Read More..

Congress' choice whether Petraeus testifies on Benghazi attack

Holly Petraeus and Gen. David Petraeus walk past a seated Paula Broadwell (rear right) at his confirmation hearing …The White House said Tuesday that it was "up to Congress" whether to call former CIA Director David Petraeus to testify about the Sept. 11 attack in Benghazi, Libya.

"Congress [makes] decisions about who is called to testify," press secretary Jay Carney told reporters at his daily briefing.

The Intelligence Committees of the Senate and House of Representatives had been set to hear from Petraeus about the attack on the American compound in separate closed-door hearings on Thursday. But aides to both panels indicated that the retired Army general would be replaced by Mike Morrell, the acting CIA director.

"The president is confident that Acting Director Morrell is fully informed and capable of representing the CIA in a hearing about the incidents in Benghazi," Carney said.

Still, key senators have made it clear that Petraeus, whose shocking resignation came after the public disclosure of an extramarital affair, will ultimately need to be heard. The attack claimed the lives of U.S. Ambassador Chris Stevens and three other Americans.

Senate Intelligence Committee Chairwoman Dianne Feinstein, a Democrat, told MSNBC on Monday that her panel "should go ahead with Mike Morell and the way it is now set up."

"But I also think that the community should know that this is not sufficient," she continued. "And I have no doubt now that we will need to talk with David Petraeus. And we will likely do that in closed session, but it will be done one way or the other."

Read More..

Panetta: Admin deciding on post-2014 troop levels

ABOARD A U.S. MILITARY AIRCRAFT OVER THE PACIFIC (AP) — Defense Secretary Leon Panetta said Monday the Obama administration is nearing a decision in the next few weeks on how many U.S. troops would remain in Afghanistan — and for what purposes — after the U.S.-led combat mission ends in 2014.

Panetta told reporters aboard his plane en route from Hawaii to Australia that Gen. John Allen, the top U.S. commander in Afghanistan, has developed several options on a post-2014 presence.

Panetta also was asked about his future at the Pentagon. While he declined to reveal his plans, he suggested he still had work to do on the job he took in July 2011.

"It's no secret that at some point I'd like to get back to California," he said. Panetta is from Monterey, Calif.

He added that there are a number of important defense issues awaiting resolution, including a budget impasse and the future of U.S. involvement in Afghanistan — suggesting that he would not leave immediately.

"Right now, my goal is to basically meet my responsibilities with regard to dealing with those issues," Panetta said.

Pressed to say whether he would rule out staying for all four years of a second Obama term, he replied, "Who the hell knows?"

Panetta said the Pentagon is reviewing those options with the White House. He would not reveal what troop levels are being considered, but it is believed that at least several thousand could be needed for several years beyond 2014.

"My hope is that we'll be able to complete this process in the next few weeks," Panetta said.

The decision will depend in part of the Afghan government's willingness to permit a post-2014 U.S. military presence and to provide legal guarantees for those troops that are acceptable to Washington.

Once that decision is made, U.S. officials have said they will set a timetable for reducing troop levels between now and the end of 2014. There now are about 67,000 U.S. troops in Afghanistan, and their mission is evolving from combat to advising, assisting and training Afghan forces.

A post-2014 U.S. military presence also would be expected to include hunting and killing extremists, including members of al-Qaida in Afghanistan.

Asked about David Petraeus's resignation as CIA director over revelations that he had an affair with his biographer, Panetta said he saw it as a "very sad situation to have him end his career like that." Panetta was CIA director before Petraeus.

"I think he took the right step" by resigning, Panetta added.

Panetta was beginning a weeklong trip to Asia to meet with his counterparts in Australia, Thailand and Cambodia. He said this was an important expression of the Obama administration's commitment to deepening ties in the region and developing more security partnerships.

For decades American administrations have fought the perception among Asians that Washington paid too little attention to their security interests. This view was reinforced during the years of U.S. focus on Iraq, and it persists even as the war in Afghanistan winds down.

The Obama administration has made much of its "pivot" to the Asia-Pacific, which has entailed more high-level diplomatic and security engagements and an attempt to expand cooperation with Australia and others in the region. But it is not fundamentally different from what the administration of President George W. Bush was pursuing even as it got mired in Iraq and saw stalemate in Afghanistan.

In June 2007, then-Defense Secretary Robert Gates argued at a security conference in Singapore that the U.S. was increasingly focused on Asia.

"Far from neglecting Asia, the U.S. is more engaged than ever before," he said. "We have been extraordinarily busy in recent years as we reshape and strengthen our security ties based on shared interests. Some are bilateral relationships that have been formed, renewed, or modernized - each with varying types and degrees of cooperation."

Among the issues dogging Panetta and the Pentagon is the controversy over the U.S. response to an attack on U.S. diplomatic facilities in Benghazi, Libya, two months ago.

Panetta said the Pentagon and the State Department are assessing what additional or improved arrangements might be necessary to secure U.S. diplomatic outposts in the Middle East. He was not specific.

As for the Benghazi attack, Panetta said it was "largely over" by the time the Pentagon was able to move forces close enough to Libya to respond.

Asked about the prospect of Congress and the administration settling for a short-term fix to the budget deficit crisis, rather than agreeing on measures to end the threat of further large defense spending cuts, Panetta said, "That's the worst thing that could happen."

He added: "That's the last damn thing I need right now," because it would perpetuate uncertainty about future defense spending and defense priorities.

Read More..

'Skyfall' brings record Bond debut of $88.4M

LOS ANGELES (AP) — James Bond is cashing in at the box office.

"Skyfall," the 23rd film featuring the British super-spy, pulled in a franchise-record $88.4 million in its U.S. debut, bringing its worldwide total to more than $500 million since it began rolling out overseas in late October.

The top 20 movies at U.S. and Canadian theaters Friday through Sunday, followed by distribution studio, gross, number of theater locations, average receipts per location, total gross and number of weeks in release, as compiled Monday by Hollywood.com are:

1. "Skyfall," Sony, $88,364,714, 3,505 locations, $25,211 average, $90,564,714, one week.

2. "Wreck-It Ralph," Disney, $33,012,796, 3,752 locations, $8,799 average, $93,647,405, two weeks.

3. "Flight," Paramount, $14,785,097, 2,047 locations, $7,223 average, $47,455,396, two weeks.

4. "Argo," Warner Bros., $6,617,229, 2,763 locations, $2,395 average, $85,583,187, five weeks.

5. "Taken 2," Fox, $4,012,829, 2,487 locations, $1,614 average, $131,300,000, six weeks.

6. "Cloud Atlas," Warner Bros., $2,658,250, 2,023 locations, $1,314 average, $22,844,956, three weeks.

7. "The Man With the Iron Fists," Universal, $2,592,705, 1,872 locations, $1,385 average, $12,821,030, two weeks.

8. "Pitch Perfect," Universal, $2,573,350, 1,391 locations, $1,850 average, $59,099,993, seven weeks.

9. "Here Comes the Boom," Sony, $2,522,790, 2,044 locations, $1,234 average, $39,033,885, five weeks.

10. "Hotel Transylvania," Sony, $2,400,226, 2,566 locations, $935 average, $140,954,208, seven weeks.

11. "Paranormal Activity 4," Paramount, $1,980,033, 2,348 locations, $843 average, $52,600,612, four weeks.

12. "Sinister," Summit, $1,524,448, 1,554 locations, $981 average, $46,578,686, five weeks.

13. "Silent Hill: Revelation," Open Road Films, $1,300,137, 1,902 locations, $684 average, $16,383,406, three weeks.

14. "The Perks of Being a Wallflower," Summit, $1,132,924, 607 locations, $1,866 average, $14,614,770, eight weeks.

15. "Lincoln," Disney, $944,308, 11 locations, $85,846 average, $944,308, one week.

16. "Alex Cross," Summit, $911,973, 1,090 locations, $837 average, $24,603,042, four weeks.

17. "Fun Size," Paramount, $757,223, 1,301 locations, $582 average, $8,800,336, three weeks.

18. "Looper," Sony, $582,150, 491 locations, $1,186 average, $64,669,383, seven weeks.

19. "The Sessions," Fox, $545,550, 128 locations, $4,262 average, $1,655,222, four weeks.

20. "Seven Psychopaths," CBS Films, $404,812, 356 locations, $1,137 average, $14,098,469, five weeks.

___

Universal and Focus are owned by NBC Universal, a unit of Comcast Corp.; Sony, Columbia, Sony Screen Gems and Sony Pictures Classics are units of Sony Corp.; Paramount is owned by Viacom Inc.; Disney, Pixar and Marvel are owned by The Walt Disney Co.; Miramax is owned by Filmyard Holdings LLC; 20th Century Fox and Fox Searchlight are owned by News Corp.; Warner Bros. and New Line are units of Time Warner Inc.; MGM is owned by a group of former creditors including Highland Capital, Anchorage Advisors and Carl Icahn; Lionsgate is owned by Lions Gate Entertainment Corp.; IFC is owned by AMC Networks Inc.; Rogue is owned by Relativity Media LLC.

___

Online:

http://www.hollywood.com

Read More..

British medical journal slams Roche on Tamiflu

LONDON (AP) — A leading British medical journal is asking the drug maker Roche to release all its data on Tamiflu, claiming there is no evidence the drug can actually stop the flu.

The drug has been stockpiled by dozens of governments worldwide in case of a global flu outbreak and was widely used during the 2009 swine flu pandemic.

On Monday, one of the researchers linked to the BMJ journal called for European governments to sue Roche.

"I suggest we boycott Roche's products until they publish missing Tamiflu data," wrote Peter Gotzsche, leader of the Nordic Cochrane Centre in Copenhagen. He said governments should take legal action against Roche to get the money back that was "needlessly" spent on stockpiling Tamiflu.

Last year, Tamiflu was included in a list of "essential medicines" by the World Health Organization, a list that often prompts governments or donor agencies to buy the drug.

Tamiflu is used to treat both seasonal flu and new flu viruses like bird flu or swine flu. WHO spokesman Gregory Hartl said the agency had enough proof to warrant its use for unusual influenza viruses, like bird flu.

"We do have substantive evidence it can stop or hinder progression to severe disease like pneumonia," he said.

In the U.S., the Centers for Disease Control and Prevention recommends Tamiflu as one of two medications for treating regular flu. The other is GlaxoSmithKline's Relenza. The CDC says such antivirals can shorten the duration of symptoms and reduce the risk of complications and hospitalization.

In 2009, the BMJ and researchers at the Nordic Cochrane Centre asked Roche to make all its Tamiflu data available. At the time, Cochrane Centre scientists were commissioned by Britain to evaluate flu drugs. They found no proof that Tamiflu reduced the number of complications in people with influenza.

"Despite a public promise to release (internal company reports) for each (Tamiflu) trial...Roche has stonewalled," BMJ editor Fiona Godlee wrote in an editorial last month.

In a statement, Roche said it had complied with all legal requirements on publishing data and provided Gotzsche and his colleagues with 3,200 pages of information to answer their questions.

"Roche has made full clinical study data ... available to national health authorities according to their various requirements, so they can conduct their own analyses," the company said.

Roche says it doesn't usually release patient-level data available due to legal or confidentiality constraints. It said it did not provide the requested data to the scientists because they refused to sign a confidentiality agreement.

Roche is also being investigated by the European Medicines Agency for not properly reporting side effects, including possible deaths, for 19 drugs including Tamiflu that were used in about 80,000 patients in the U.S.

____

Online:

www.bmj.com.tamiflu/

Read More..

Did Petraeus' mistress leak classified info?

Former CIA Director David Petraeus and author Paula Broadwell pose for a photo. (AP)A recent University of Denver address by Paula Broadwell has set off a torrent of speculation as to whether her affair with Gen. David Petraeus resulted in a leak of classified national security information.

New York magazine got things started by posting a video of Broadwell, author of Petraeus' biography, "All In," discussing details of the Sept. 11 attack on the American Consulate in Benghazi, Libya, at the Oct. 26 talk.

In the video, since posted by several sources to YouTube, Broadwell states: "Now, I don't know if a lot of you heard this, but the CIA annex had actually, had taken a couple of Libyan militia members prisoner, and they think that the attack on the consulate was an effort to try to get these prisoners back. So that's still being vetted."

That clip has led some to speculate whether Broadwell was exposing previously unreported details about the attack.

Other major media outlets, including CBS News and The Daily Beast, have picked up on the video clip. Wired goes a step further, stating as fact that Broadwell did reveal new information, writing: "It was a surprising disclosure, given the deep classification of the CIA's detention policies—and the enormous political stakes surrounding the Benghazi assault. But in many ways, it was only natural for Broadwell, given her evolution from Petraeus protegee to biographer to paramour and unofficial spokesperson."

And Politico points to a July panel discussion at the Aspen Security Forum during which Broadwell claims to have had access to classified information and to have attended high-level security meetings with Petraeus.

However, Broadwell's sound bite could be entirely innocuous, New York magazine notes: "It's also possible that she just misunderstood something she heard on Fox News."

The Fox News Channel reference concerns a report FNC reporter Jennifer Griffin made earlier the same day as Broadwell's university address, in which Griffin cited sources claiming that the CIA was holding high-value detainees in the Benghazi facility at the time of the attack.

You can watch an excerpt from Broadwell's University of Denver address below:

Griffin has since updated her reporting, noting that a well-placed Washington source confirms that Libyan militiamen were being held at the CIA annex and may have been a possible reason for the attack. Multiple intelligence sources, she also reported, said "there were more than just Libyan militia members who were held and interrogated by CIA contractors at the CIA annex in the days prior to the attack. Other prisoners from additional countries in Africa and the Middle East were brought to this location."

The CIA has denied keeping militants at the facility. CIA spokesman Preston Golson said, "Any suggestion that the agency is still in the detention business is uninformed and baseless."

Basically, so far we have a lot of speculation, with individuals commenting on a potential national security leak concerning details of a situation the government says never took place. Stay tuned.

Read More..

Man in Afghan uniform kills British soldier

KABUL, Afghanistan (AP) — A gunman wearing an Afghan army uniform shot and killed a member of the U.S.-led coalition forces fighting in Afghanistan on Sunday -- the latest in a spate of insider attacks that are fracturing the trust between NATO and Afghan forces.

Separately, officials said 11 Afghan civilians were killed by land mines on Sunday in explosions in the east and south.

The U.K. Ministry of Defense confirmed that the insider attack had claimed the life of a British soldier from The Royal Scots Borderers, 1st Battalion The Royal Regiment of Scotland. It said the soldier was shot by an individual wearing an Afghan army uniform at his base in the Nade-e Ali district of Helmand province.

The defense ministry did not name the serviceman but said his next of kin have been informed.

Mohammad Zarak, spokesman for the governor of southern Afghanistan's Helmand province, said the shooting took place in Nad Ali district after an argument between an Afghan soldier and coalition service members.

Coalition figures show at least 60 coalition service members have been killed so far this year and others have been wounded in about 45 insider attacks, where members of the Afghan security forces or insurgents dressed in their uniforms turn their guns on U.S. and allied troops.

The insider attacks have raised questions about how effectively the allied forces can train the Afghans to take over security of their own country in 2014 and beyond. Foreign forces are due to turn over security responsibility to the local military by the end of 2014.

A roadside bomb killed three men, two women and a baby in Khost province of eastern Afghanistan, deputy provincial police chief Youqib Khan said. He said their vehicle hit the bomb as they were returning from a hospital.

Three other civilians were killed when their vehicle detonated a land mine on the road between Helmand and Kandahar provinces, a government statement said.

Also in the south, two civilians who were walking were killed by a land mine in Khakrez district of Kandahar province, said Ahmad Jawed Faisal, a spokesman for the provincial governor.

The United Nations says homemade bombs continue to be the weapons that kill the most civilians in the war.

___

Associated Press Writers Rahim Faiez, Mirwais Khan and Cassandra Vinograd contributed to this report.

Read More..